Why are we still struggling to get contraception right?

--:--
As the pill becomes available over the counter and free of charge in England, Madeleine Finlay talks to science correspondent Nicola Davis about the problems women in the UK face in getting access to appropriate contraception, and how unwanted side-effects and lack of support have led to a rise in the popularity of fertility awareness-based methods. She also hears from Katie about her own journey trying to find the right contraception for her body. Help support our independent journalism at theguardian.com/sciencepod
4 Dec 2023 English United Kingdom Science · Nature

Other recent episodes

Nitazenes and xylazine: what’s behind the rise of dangerous synthetic drugs?

Social affairs correspondent Robert Booth tells Madeleine Finlay why a class of synthetic opioids called nitazenes, first developed in the 1950s, is leading to a worrying number of fatal overdoses in the UK. And she hears from toxicology and addiction specialist Dr Joseph D’Orazio about a tranquilliser called xylazine that…
19 Feb 16 min

What apes can tell us about the origins of teasing

We all know people who find it hilarious to prod and poke, pinch and tickle, all in the name of fun. But are humans the only ones who like to tease each other? Or are other animals in on the act? Ian Sample talks to Prof Erica Cartmill about her…
14 Feb 15 min

Retinol, acids and serums: why are children obsessed with anti-ageing products?

Last month the British Association of Dermatologists warned that children as young as eight years old were using potentially damaging anti-ageing skin care products. Madeleine Finlay speaks to consultant dermatologist Dr Emma Wedgeworth about where this trend has come from, what damage these products might be causing to young skin…
12 Feb 15 min

Why are we still waiting for a male contraceptive pill?

Despite research into a male contraceptive pill starting around the same time as its female counterpart, no product has ever made it to market. But that could soon change, with a new non-hormonal male pill entering human trials in the UK late last year. Ian Sample speaks to bioethicist Prof…
7 Feb 17 min